Cleveland Business Journal: Stan Gerson, interim dean of the School of Medicine, discussed the far-reaching impact of Athersys in the community, as the company’s CEO Gil van Bokkelen stepped down from his post.

Medicine's Stan Gerson weighs in on the impact of Athersys in the community
MEDIA |
February 25, 2021
STORY BY: EDITORIAL STAFF
STORY BY: EDITORIAL STAFF